Nota Bene Cancer
Nota Bene Cancer est un bulletin hebdomadaire de veille bibliographique. En libre accès, Nota Bene Cancer permet à ses abonnés de gagner du temps pour se tenir informé de l’actualité scientifique et médicale dans les divers domaines de la recherche sur les cancers.
Rechercher des publications
Pour retrouver les publications signalées par Nota Bene Cancer (archives indexées à partir du n°127 du 1" mars 2012) :
Sommaire du n° 488 du 29 avril 2021
Lutte contre les cancers
Qualité de vie, soins de support (3)
Ce dossier présente un ensemble d'articles portant sur les effets neurocognitifs des traitements anticancéreux chez des patients ayant survécu à un cancer pédiatrique ainsi que sur les enjeux liés à leur prise en charge
Aging in Adult Survivors of Childhood Cancer: Implications for Future Care
Ce dossier présente un ensemble d'articles portant sur les effets neurocognitifs des traitements anticancéreux chez des patients ayant survécu à un cancer pédiatrique ainsi que sur les enjeux liés à leur prise en charge
Aging in Adult Survivors of Childhood Cancer: Implications for Future Care
Ilse Schuitema ; Tyler Alexander ; Melissa M. Hudson ; Kevin R. Krull ; Kim Edelstein
Changes to diagnostic and treatmant protocols for pediatric cancer have improved survival. (...)
Addressing Neurocognitive Late Effects in Pediatric Cancer Survivors: Current Approaches and Future Opportunities
Ce dossier présente un ensemble d'articles portant sur les effets neurocognitifs des traitements anticancéreux chez des patients ayant survécu à un cancer pédiatrique ainsi que sur les enjeux liés à leur prise en charge
Addressing Neurocognitive Late Effects in Pediatric Cancer Survivors: Current Approaches and Future Opportunities
Matthew C. Hocking ; Karin S. Walsh ; Kristina K. Hardy ; Heather M. Conklin
Survivors of childhood cancers are at risk for neurocognitive late effects secondary to their disease and treatment. (...)
Assessment and Monitoring of Neurocognitive Function in Pediatric Cancer
Ce dossier présente un ensemble d'articles portant sur les effets neurocognitifs des traitements anticancéreux chez des patients ayant survécu à un cancer pédiatrique ainsi que sur les enjeux liés à leur prise en charge
Assessment and Monitoring of Neurocognitive Function in Pediatric Cancer
Lisa M. Jacola ; Marita Partanen ; Jurgen Lemiere ; Melissa M. Hudson ; Sophie Thomas
Cognitive late effects are among the most common life-altering sequelae of childhood cancer, which reported prevalence ranging from 35% to 60% depending on specific diagnostic and treatment groups (...)
Brain Imaging in Pediatric Cancer Survivors: Correlates of Cognitive Impairment
Ce dossier présente un ensemble d'articles portant sur les effets neurocognitifs des traitements anticancéreux chez des patients ayant survécu à un cancer pédiatrique ainsi que sur les enjeux liés à leur prise en charge
Brain Imaging in Pediatric Cancer Survivors: Correlates of Cognitive Impairment
Shelli R. Kesler ; Charlotte Sleurs ; Brenna C. McDonald ; Sabine Deprez ; Ellen van der Plas ; Brian J. Nieman
Pediatric cancer and its treatment are associated with increased risk for acute and chronic cognitive impairments. (...)
Health Behaviors and Neurocognitive Function in Survivors of Childhood Cancer
Ce dossier présente un ensemble d'articles portant sur les effets neurocognitifs des traitements anticancéreux chez des patients ayant survécu à un cancer pédiatrique ainsi que sur les enjeux liés à leur prise en charge
Health Behaviors and Neurocognitive Function in Survivors of Childhood Cancer
Alicia S. Kunin-Batson ; James L. Klosky ; Bonnie Carlson-Green ; Tara M. Brinkman
Among childhood cancer survivors, health behaviors play a critical role in reducing risk for subsequent malignancies and chronic health conditions (...)
Cognitive Risk in Survivors of Pediatric Brain Tumors
Ce dossier présente un ensemble d'articles portant sur les effets neurocognitifs des traitements anticancéreux chez des patients ayant survécu à un cancer pédiatrique ainsi que sur les enjeux liés à leur prise en charge
Cognitive Risk in Survivors of Pediatric Brain Tumors
Ade Oyefiade ; Iris Paltin ; Cinzia R. De Luca ; Kristina K. Hardy ; David R. Grosshans ; Murali Chintagumpala ; Donald J. Mabbott ; Lisa S. Kahalley
Pediatric brain tumors (PBTs), the most common solid tumors of childhood, are a leading cause of cancer-related morbidity (...)
Neurotoxic Effects of Childhood Cancer Therapy and Its Potential Neurocognitive Impact
Ce dossier présente un ensemble d'articles portant sur les effets neurocognitifs des traitements anticancéreux chez des patients ayant survécu à un cancer pédiatrique ainsi que sur les enjeux liés à leur prise en charge
Neurotoxic Effects of Childhood Cancer Therapy and Its Potential Neurocognitive Impact
Nicholas S. Phillips ; Elizabeth S. Duke ; Hannah-Lise T. Schofield ; Nicole J. Ullrich
A new era of treatment for childhood cancer has welcomed an increasing number of long-term survivors, for whom acute and late neurologic and neurocognitive sequelae related to their cancer and treatment directly affects overall cognitive functioning. (...)
Cognitive Impairment in Survivors of Pediatric Acute Lymphoblastic Leukemia Treated With Chemotherapy Only
Ce dossier présente un ensemble d'articles portant sur les effets neurocognitifs des traitements anticancéreux chez des patients ayant survécu à un cancer pédiatrique ainsi que sur les enjeux liés à leur prise en charge
Cognitive Impairment in Survivors of Pediatric Acute Lymphoblastic Leukemia Treated With Chemotherapy Only
Ellen van der Plas ; Arunkumar J. Modi ; Chi Kong Li ; Kevin R. Krull ; Yin Ting Cheung
Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, accounting for nearly 25% of all childhood cancers. (...)
Cognitive Impairment and Family Functioning of Survivors of Pediatric Cancer: A Systematic Review
Ce dossier présente un ensemble d'articles portant sur les effets neurocognitifs des traitements anticancéreux chez des patients ayant survécu à un cancer pédiatrique ainsi que sur les enjeux liés à leur prise en charge
Cognitive Impairment and Family Functioning of Survivors of Pediatric Cancer: A Systematic Review
Sasja A. Schepers ; Fiona S. M. Schulte ; Sunita K. Patel ; Kathryn Vannatta
Improved survival for children with cancer has led to a growing emphasis on the long-term consequences of aggressive treatments on the quality of survivorship (...)
A partir d'une revue systématique de la littérature, cette étude fait le point sur les pratiques de prise en charge de la douleur des patients atteints d'un cancer du pancréas
Pancreatic Cancer–Associated Pain Management
A partir d'une revue systématique de la littérature, cette étude fait le point sur les pratiques de prise en charge de la douleur des patients atteints d'un cancer du pancréas
Pancreatic Cancer–Associated Pain Management
Coveler, AndrewL. ; Mizrahi, Jonathan ; Eastman, Bory ; Apisarnthanarax, Smith “Jim” ; Dalal, Shalini ; McNearney, Terry ; Pant, Shubham ; the Precision Promise Consortium
Abstract : Pain is highly prevalent in patients with pancreatic cancer and contributes to the morbidity of the disease. Pain may be due to pancreatic enzyme insufficiency, obstruction, and/or a direct mass effect on nerves in the celiac plexus. Proper supportive care to decrease pain is an important aspect of the overall management of these patients. There are limited data specific to the management of pain caused by pancreatic cancer. Here we review the literature and offer recommendations [...]
A partir d'une revue de la littérature, cette étude présente différentes stratégies (pharmacologiques et non phamarcologiques, médecines complémentaires et alternatives) pour prendre en charge les effets indésirables des traitements endocriniens adjuvants chez des patientes atteintes d'un cancer du sein
Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer
A partir d'une revue de la littérature, cette étude présente différentes stratégies (pharmacologiques et non phamarcologiques, médecines complémentaires et alternatives) pour prendre en charge les effets indésirables des traitements endocriniens adjuvants chez des patientes atteintes d'un cancer du sein
Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer
Franzoi, Maria Alice ; Agostinetto, Elisa ; Perachino, Marta ; Del Mastro, Lucia ; de Azambuja, Evandro ; Vaz-Luis, Ines ; Partridge, Ann H. ; Lambertini, Matteo
The growing availability of more effective therapies has contributed to an increased survival of patients with breast cancer. In hormone receptor-positive early disease, increased survival is strongly correlated with the use of adjuvant endocrine therapy, but this therapy can cause side-effects that have major consequences in terms of treatment adherence and patients' quality of life. In premenopausal breast cancer survivors, these side-effects might be even more prominent due to the abrupt [...]
Observation (7)
Menée à partir des données des registres américains des cancers portant sur 45 789 patients atteints d'un carcinome hépatocellulaire diagnostiqué entre 2000 et 2015, cette étude analyse les disparités ethniques et socioéconomiques dans l'incidence de la maladie, le stade au diagnostic et la survie
Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study
Menée à partir des données des registres américains des cancers portant sur 45 789 patients atteints d'un carcinome hépatocellulaire diagnostiqué entre 2000 et 2015, cette étude analyse les disparités ethniques et socioéconomiques dans l'incidence de la maladie, le stade au diagnostic et la survie
Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study
Flores, Yvonne N. ; Datta, Geetanjali D. ; Yang, Liu ; Corona, Edgar ; Devineni, Divya ; Glenn, Beth A. ; Bastani, Roshan ; May, Folasade P.
Background: Liver cancer is one of the most rapidly increasing cancers in the United States, and hepatocellular carcinoma (HCC) is its most common form. Disease burden and risk factors differ by sex and race/ethnicity, but a comprehensive analysis of disparities by socioeconomic status (SES) is lacking. We examined the relative impact of race/ethnicity, sex, and SES on HCC incidence, stage, and survival. Methods: We used Surveillance, Epidemiology, and End Results (SEER) 18 data to identify [...]
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Financial toxicity, mental health, and gynecologic cancer treatment: The effect of the coronavirus disease 2019 (COVID-19) pandemic among low-incom...
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Financial toxicity, mental health, and gynecologic cancer treatment: The effect of the coronavirus disease 2019 (COVID-19) pandemic among low-income women in New York City
Chen, Yiting Stefanie ; Zhou, Zhen Ni ; Glynn, Shannon M. ; Frey, Melissa K. ; Balogun, Onyinye D. ; Kanis, Margaux ; Holcomb, Kevin ; Gorelick, Constantine ; Thomas, Charlene ; Christos, Paul J. ; Chapman-Davis, Eloise
BACKGROUND : New York City (NYC) emerged as an epicenter of the novel coronavirus disease 2019 (COVID‐19) pandemic, and marginalized populations were affected at disproportionate rates. The authors sought to determine the impact of COVID‐19 on cancer treatment, anxiety, and financial distress among low‐income patients with gynecologic cancer during the peak of the NYC pandemic. METHODS : Medicaid‐insured women who were receiving gynecologic oncology care at 2 affiliated centers were contacted [...]
Reassurance of patients with cancer on cancer care continuum: a vital strategy to prevent anxiety of COVID-19 collateral damage
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Reassurance of patients with cancer on cancer care continuum: a vital strategy to prevent anxiety of COVID-19 collateral damage
Guven, Deniz Can
I read with great interest the remarkable study by Miaskowski et al. [1] evaluating oncology patients’ perceptions and experiences with COVID-19. They reported a good level of COVID-19 knowledge and good compliance to COVID-19 precautions in their cohort. However, a significant rate of COVID-19 contraction fear and the fear of poor outcomes in COVID-19 was concerning. A significant portion of the patients anticipated a low likelihood of survival after COVID-19 contraction [1].
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective obse...
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
Monin, Leticia ; Laing, Adam G. ; Muñoz-Ruiz, Miguel ; McKenzie, Duncan R. ; del Molino del Barrio, Irene ; Alaguthurai, Thanussuyah ; Domingo-Vila, Clara ; Hayday, Thomas S. ; Graham, Carl ; Seow, Jeffrey ; Abdul-Jawad, Sultan ; Kamdar, Shraddha ; Harvey-Jones, Elizabeth ; Graham, Rosalind ; Cooper, Jack ; Khan, Muhammad ; Vidler, Jennifer ; Kakkassery, Helen ; Sinha, Shubhankar ; Davis, Richard ; Dupont, Liane ; Francos Quijorna, Isaac ; O'Brien-Gore, Charlotte ; Lee, Puay Ling ; Eum, Josephine ; Conde Poole, Maria ; Joseph, Magdalene ; Davies, Daniel ; Wu, Yin ; Swampillai, Angela ; North, Bernard V. ; Montes, Ana ; Harries, Mark ; Rigg, Anne ; Spicer, James ; Malim, Michael H. ; Fields, Paul ; Patten, Piers ; Di Rosa, Francesca ; Papa, Sophie ; Tree, Timothy ; Doores, Katie J. ; Hayday, Adrian C. ; Irshad, Sheeba
Background: The efficacy and safety profiles of vaccines against SARS-CoV-2 in patients with cancer is unknown. We aimed to assess the safety and immunogenicity of the BNT162b2 (Pfizer–BioNTech) vaccine in patients with cancer. Methods: For this prospective observational study, we recruited patients with cancer and healthy controls (mostly health-care workers) from three London hospitals between Dec 8, 2020, and Feb 18, 2021. Participants who were vaccinated between Dec 8 and Dec 29, 2020, [...]
Lung Cancer and Heart Disease Risks Associated with Low-Dose Pulmonary Radiotherapy to COVID-19 Patients with Different Background Risks
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Lung Cancer and Heart Disease Risks Associated with Low-Dose Pulmonary Radiotherapy to COVID-19 Patients with Different Background Risks
Shuryak, Igor ; Kachnic, Lisa A. ; Brenner, David J.
Purpose : The respiratory disease COVID-19 reached global pandemic status in 2020. Excessive inflammation is believed to result in the most severe symptoms and death from this disease. Since treatment options for patients with severe COVID-19 related pulmonary symptoms remain limited, whole-lung low-dose radiotherapy is being evaluated as an anti-inflammatory modality. However, there is concern about the long-term risks associated with low-dose pulmonary irradiation. To help quantify the [...]
COVID-19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population- and Registry-Based Study
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
COVID-19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population- and Registry-Based Study
Vrdoljak, Eduard ; Balja, Melita Perić ; Marušić, Zlatko ; Avirović, Manuela ; Blažičević, Valerija ; Tomasović, Čedna ; Čerina, Dora ; Bajić, Žarko ; Miše, Branka Petrić ; Lovasić, Ingrid Belac ; Flam, Josipa ; Tomić, Snježana
Background: Our objective was to assess the effects of COVID-19 antiepidemic measures and subsequent changes in the function of the health care system on the number of newly diagnosed breast cancers in the Republic of Croatia. Subjects, Materials, and Methods: We performed a retrospective, population- and registry-based study during 2020. The comparator was the number of patients newly diagnosed with breast cancer during 2017, 2018, and 2019. The outcome was the change in number of newly [...]
Cocooning against COVID-19: The argument for vaccinating caregivers of patients with cancer
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Cocooning against COVID-19: The argument for vaccinating caregivers of patients with cancer
Woodfield, Maresa C. ; Pergam, Steven A. ; Shah, Parth D.
Current national COVID-19 vaccination guidelines and recommendations focus vaccine guidance on patients with cancer. In this COVID-19 vaccination race, “cocoon vaccination” strategies which include informal caregivers and household contacts as priority groups for SARS-CoV-2 vaccination could be an additional strategy used to protect patients with cancer who may have limited immune responses to current vaccinations. Medical systems specializing in cancer care should support education and [...]
Cancer and COVID-19 vaccines: a complex global picture
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Cancer and COVID-19 vaccines: a complex global picture
Yusuf, Aasim ; Sarfati, Diana ; Booth, Christopher M. ; Pramesh, C. S. ; Lombe, Dorothy ; Aggarwal, Ajay ; Bhoo-Pathy, Nirmala ; Tsunoda, Audrey ; Vanderpuye, Verna ; Kutluk, Tezer ; Sullivan, Alice ; Mukherji, Deborah ; Mutebi, Miriam ; Van Hemelrijck, Mieke ; Sullivan, Richard
Patients with cancer can be at high risk of severe COVID-19 due to their age, disease, cancer treatment, and medical co-morbidities.1 The pandemic has also led to substantial disruptions to diagnosis and treatment in many parts of the world.2, 3 Patients with cancer in low-income and middle-income countries (LMICs) are further disadvantaged compared with those in high-income settings because of unequal access to COVID-19 vaccines in already fragile health-care systems. [...]
Ce dossier présente un ensemble d'articles portant sur les effets neurocognitifs des traitements anticancéreux chez des patients ayant survécu à un cancer pédiatrique ainsi que sur les enjeux liés à leur prise en charge
Aging in Adult Survivors of Childhood Cancer: Implications for Future Care
Ce dossier présente un ensemble d'articles portant sur les effets neurocognitifs des traitements anticancéreux chez des patients ayant survécu à un cancer pédiatrique ainsi que sur les enjeux liés à leur prise en charge
Aging in Adult Survivors of Childhood Cancer: Implications for Future Care
Ilse Schuitema ; Tyler Alexander ; Melissa M. Hudson ; Kevin R. Krull ; Kim Edelstein
Changes to diagnostic and treatmant protocols for pediatric cancer have improved survival. (...)
Addressing Neurocognitive Late Effects in Pediatric Cancer Survivors: Current Approaches and Future Opportunities
Ce dossier présente un ensemble d'articles portant sur les effets neurocognitifs des traitements anticancéreux chez des patients ayant survécu à un cancer pédiatrique ainsi que sur les enjeux liés à leur prise en charge
Addressing Neurocognitive Late Effects in Pediatric Cancer Survivors: Current Approaches and Future Opportunities
Matthew C. Hocking ; Karin S. Walsh ; Kristina K. Hardy ; Heather M. Conklin
Survivors of childhood cancers are at risk for neurocognitive late effects secondary to their disease and treatment. (...)
Assessment and Monitoring of Neurocognitive Function in Pediatric Cancer
Ce dossier présente un ensemble d'articles portant sur les effets neurocognitifs des traitements anticancéreux chez des patients ayant survécu à un cancer pédiatrique ainsi que sur les enjeux liés à leur prise en charge
Assessment and Monitoring of Neurocognitive Function in Pediatric Cancer
Lisa M. Jacola ; Marita Partanen ; Jurgen Lemiere ; Melissa M. Hudson ; Sophie Thomas
Cognitive late effects are among the most common life-altering sequelae of childhood cancer, which reported prevalence ranging from 35% to 60% depending on specific diagnostic and treatment groups (...)
Brain Imaging in Pediatric Cancer Survivors: Correlates of Cognitive Impairment
Ce dossier présente un ensemble d'articles portant sur les effets neurocognitifs des traitements anticancéreux chez des patients ayant survécu à un cancer pédiatrique ainsi que sur les enjeux liés à leur prise en charge
Brain Imaging in Pediatric Cancer Survivors: Correlates of Cognitive Impairment
Shelli R. Kesler ; Charlotte Sleurs ; Brenna C. McDonald ; Sabine Deprez ; Ellen van der Plas ; Brian J. Nieman
Pediatric cancer and its treatment are associated with increased risk for acute and chronic cognitive impairments. (...)
Health Behaviors and Neurocognitive Function in Survivors of Childhood Cancer
Ce dossier présente un ensemble d'articles portant sur les effets neurocognitifs des traitements anticancéreux chez des patients ayant survécu à un cancer pédiatrique ainsi que sur les enjeux liés à leur prise en charge
Health Behaviors and Neurocognitive Function in Survivors of Childhood Cancer
Alicia S. Kunin-Batson ; James L. Klosky ; Bonnie Carlson-Green ; Tara M. Brinkman
Among childhood cancer survivors, health behaviors play a critical role in reducing risk for subsequent malignancies and chronic health conditions (...)
Cognitive Risk in Survivors of Pediatric Brain Tumors
Ce dossier présente un ensemble d'articles portant sur les effets neurocognitifs des traitements anticancéreux chez des patients ayant survécu à un cancer pédiatrique ainsi que sur les enjeux liés à leur prise en charge
Cognitive Risk in Survivors of Pediatric Brain Tumors
Ade Oyefiade ; Iris Paltin ; Cinzia R. De Luca ; Kristina K. Hardy ; David R. Grosshans ; Murali Chintagumpala ; Donald J. Mabbott ; Lisa S. Kahalley
Pediatric brain tumors (PBTs), the most common solid tumors of childhood, are a leading cause of cancer-related morbidity (...)
Neurotoxic Effects of Childhood Cancer Therapy and Its Potential Neurocognitive Impact
Ce dossier présente un ensemble d'articles portant sur les effets neurocognitifs des traitements anticancéreux chez des patients ayant survécu à un cancer pédiatrique ainsi que sur les enjeux liés à leur prise en charge
Neurotoxic Effects of Childhood Cancer Therapy and Its Potential Neurocognitive Impact
Nicholas S. Phillips ; Elizabeth S. Duke ; Hannah-Lise T. Schofield ; Nicole J. Ullrich
A new era of treatment for childhood cancer has welcomed an increasing number of long-term survivors, for whom acute and late neurologic and neurocognitive sequelae related to their cancer and treatment directly affects overall cognitive functioning. (...)
Cognitive Impairment in Survivors of Pediatric Acute Lymphoblastic Leukemia Treated With Chemotherapy Only
Ce dossier présente un ensemble d'articles portant sur les effets neurocognitifs des traitements anticancéreux chez des patients ayant survécu à un cancer pédiatrique ainsi que sur les enjeux liés à leur prise en charge
Cognitive Impairment in Survivors of Pediatric Acute Lymphoblastic Leukemia Treated With Chemotherapy Only
Ellen van der Plas ; Arunkumar J. Modi ; Chi Kong Li ; Kevin R. Krull ; Yin Ting Cheung
Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, accounting for nearly 25% of all childhood cancers. (...)
Cognitive Impairment and Family Functioning of Survivors of Pediatric Cancer: A Systematic Review
Ce dossier présente un ensemble d'articles portant sur les effets neurocognitifs des traitements anticancéreux chez des patients ayant survécu à un cancer pédiatrique ainsi que sur les enjeux liés à leur prise en charge
Cognitive Impairment and Family Functioning of Survivors of Pediatric Cancer: A Systematic Review
Sasja A. Schepers ; Fiona S. M. Schulte ; Sunita K. Patel ; Kathryn Vannatta
Improved survival for children with cancer has led to a growing emphasis on the long-term consequences of aggressive treatments on the quality of survivorship (...)
Menée aux Etats-Unis à partir de données portant sur 38 366 patients ayant survécu à un cancer, cette étude de cohorte rétrospective analyse les facteurs associés à une utilisation d'opioïdes
Predictors of Chronic Opioid Use: A Population-level Analysis of North Carolina Cancer Survivors Using Multi-Payer Claims
Menée aux Etats-Unis à partir de données portant sur 38 366 patients ayant survécu à un cancer, cette étude de cohorte rétrospective analyse les facteurs associés à une utilisation d'opioïdes
Predictors of Chronic Opioid Use: A Population-level Analysis of North Carolina Cancer Survivors Using Multi-Payer Claims
Check, Devon K ; Bagett, Christopher D ; Kim, KyungSu ; Roberts, Andrew W ; Roberts, Megan C ; Robinson, Timothy ; Oeffinger, Kevin C ; Dinan, Michaela A
Background : No population-based studies have examined chronic opioid use among cancer survivors who are diverse with respect to diagnosis, age group, and insurance status. Methods : We conducted a retrospective cohort study using North Carolina (NC) cancer registry data linked with claims from public and private insurance (2006–2016). We included adults with non-metastatic cancer who had no prior chronic opioid use (N = 38,366). We used modified Poisson regression to assess the adjusted [...]
Menée à partir des données des registres américains des cancers portant sur 311 691 patients atteints d'un cancer de la prostate diagnostiqué entre 2004 et 2015, cette étude analyse les disparités ethniques dans l'association entre l'accès aux soins et la mortalité spécifique
Association of Health-Care System with Prostate Cancer-Specific Mortality in African American and Non-Hispanic White Men
Menée à partir des données des registres américains des cancers portant sur 311 691 patients atteints d'un cancer de la prostate diagnostiqué entre 2004 et 2015, cette étude analyse les disparités ethniques dans l'association entre l'accès aux soins et la mortalité spécifique
Association of Health-Care System with Prostate Cancer-Specific Mortality in African American and Non-Hispanic White Men
Klebaner, Daniella ; Travis Courtney, P ; Garraway, Isla P ; Einck, John ; Kumar, Abhishek ; Elena Martinez, Maria ; McKay, Rana ; Murphy, James D ; Parada, Humberto ; Sandhu, Ajay ; Stewart, Tyler ; Yamoah, Kosj ; Rose, Brent S
Background : Disparities in prostate cancer-specific mortality (PCSM) between African American and non-Hispanic White (White) patients have been attributed to biological and systemic factors. We evaluated drivers of these disparities in the Surveillance, Epidemiology and End Results (SEER) national registry and an equal-access system, the Veterans Health Administration (VHA). Methods : We identified African American and White patients diagnosed with prostate cancer between 2004–2015 in SEER [...]
Menée à partir des données des registres finlandais des cancers portant sur 50 481 patientes atteintes d'un cancer du sein diagnostiqué entre 1971 et 2000, cette étude analyse les causes de décès
Causes of death among women with breast cancer: A follow-up study of 50,481 women with breast cancer in Finland
Menée à partir des données des registres finlandais des cancers portant sur 50 481 patientes atteintes d'un cancer du sein diagnostiqué entre 1971 et 2000, cette étude analyse les causes de décès
Causes of death among women with breast cancer: A follow-up study of 50,481 women with breast cancer in Finland
Katuwal, Sushmita ; Jousilahti, Pekka ; Pukkala, Eero
This study aims to assess mortality from causes other than breast cancer among women with breast cancer with focus on indications of joint aetiology. Data on female breast cancer patients were obtained from the Finnish Cancer Registry and their underlying causes of death in 54 categories from the Statistics Finland. Standardized mortality ratios (SMR) and their 95% confidence intervals (CIs) were calculated for 50,481 patients diagnosed between 1971 and 2000 and followed until December 2012, [...]
A partir des données des registres américains des cancers portant sur 183 153 patientes atteintes d'un cancer de l'endomètre diagnostiqué entre 2000 et 2017, cette étude estime la survie relative à 5 ans et le taux de mortalité standardisé
Long-term Patterns of Excess Mortality among Endometrial Cancer Survivors
A partir des données des registres américains des cancers portant sur 183 153 patientes atteintes d'un cancer de l'endomètre diagnostiqué entre 2000 et 2017, cette étude estime la survie relative à 5 ans et le taux de mortalité standardisé
Long-term Patterns of Excess Mortality among Endometrial Cancer Survivors
Anderson, Chelsea ; Bae-Jump, Victoria L. ; Broaddus, Russell R. ; Olshan, Andrew F. ; Nichols, Hazel B.
Background: We investigated excess mortality after endometrial cancer using conditional relative survival estimates and standardized mortality ratios (SMR). Methods: Women diagnosed with endometrial cancer during 2000–2017 (N = 183,153) were identified in the Surveillance Epidemiology and End Results database. SMRs were calculated as observed deaths among endometrial cancer survivors over expected deaths among demographically similar women in the general U.S. population. Five-year relative [...]
Approches psycho-sociales (3)
Menée aux Pays-Bas à partir de données de registres portant sur 377 patients atteints d'un cancer de stade avancé, cette étude analyse l'association entre leurs perceptions négatives de la maladie, des symptômes d'anxiété et de dépression, et la qualité de vie
Untangling the relationship between negative illness perceptions and worse quality of life in patients with advanced cancer—a study from the popula...
Menée aux Pays-Bas à partir de données de registres portant sur 377 patients atteints d'un cancer de stade avancé, cette étude analyse l'association entre leurs perceptions négatives de la maladie, des symptômes d'anxiété et de dépression, et la qualité de vie
Untangling the relationship between negative illness perceptions and worse quality of life in patients with advanced cancer—a study from the population-based PROFILES registry
Jabbarian, Lea J. ; Rietjens, Judith A. C. ; Mols, Floortje ; Oude Groeniger, Joost ; van der Heide, Agnes ; Korfage, Ida J.
Purpose : Quality of life (QoL) is an important yet complex outcome of care in patients with advanced cancer. QoL is associated with physical and psychosocial symptoms and with patients’ illness perceptions (IPs). IPs are modifiable cognitive constructs developed to make sense of one’s illness. It is unclear how IPs influence patients’ QoL. A better understanding of this relationship can inform and direct high quality care aimed at improving patients’ QoL. We therefore investigated the [...]
A partir d'une revue de la littérature (9 études qualitatives et 13 études quantitatives), cette étude analyse les facteurs associés à la perception de la dignité chez des patients atteints d'un cancer
How patients with cancer experience dignity: An integrative review
A partir d'une revue de la littérature (9 études qualitatives et 13 études quantitatives), cette étude analyse les facteurs associés à la perception de la dignité chez des patients atteints d'un cancer
How patients with cancer experience dignity: An integrative review
Xiao, Jinnan ; Ng, Marques S. N. ; Yan, Tingting ; Chow, Ka Ming ; Chan, Carmen W. H.
Background : A diagnosis of cancer and its treatments can be associated with a prominent issue of loss of dignity or an undermined sense of dignity for patients. Research is increasingly being conducted into how patients with cancer experience dignity, with the aim to build clinical foundations for care that preserves patients' sense of dignity. Aim : This review summarises and synthesises the available empirical literature on the experience of dignity in patients with cancer regarding both the [...]
Menée à partir de données portant sur 98 enfants atteints d'un rétinoblastome, cette étude longitudinale analyse l'évolution de leurs fonctions cognitives et adaptatives, du diagnostic jusqu'à l'âge de 10 ans
Cognitive and Adaptive Functioning in Youth With Retinoblastoma: A Longitudinal Investigation Through 10 Years of Age
Menée à partir de données portant sur 98 enfants atteints d'un rétinoblastome, cette étude longitudinale analyse l'évolution de leurs fonctions cognitives et adaptatives, du diagnostic jusqu'à l'âge de 10 ans
Cognitive and Adaptive Functioning in Youth With Retinoblastoma: A Longitudinal Investigation Through 10 Years of Age
Victoria W. Willard ; Ibrahim Qaddoumi ; Haitao Pan ; Chia-Wei Hsu ; Rachel C. Brennan ; Matthew W. Wilson ; Carlos Rodriguez-Galindo ; Kristin Goode ; Kendra Parris ; Sean Phipps
PURPOSE : To describe the trajectory of cognitive and adaptive functioning in pediatric patients with retinoblastoma from diagnosis through age 10. This is an extension of a previous report that discussed findings from diagnosis through age 5. PATIENTS AND METHODS : Ninety-eight participants with retinoblastoma completed psychological assessments as part of their enrollment on an institutional treatment protocol, with 73 completing an additional assessment at age 10. Trajectories of adaptive [...]
Analyses économiques et systèmes de soins (1)
Menée aux Etats-Unis à partir de données 2011-2016 d'une enquête portant sur 2 326 adolescents et jeunes adultes ayant survécu à un cancer, cette étude analyse les facteurs, notamment la présence de maladies chroniques, associés à une augmentation des dépenses de santé
Additional medical costs of chronic conditions among adolescent and young adult cancer survivors
Menée aux Etats-Unis à partir de données 2011-2016 d'une enquête portant sur 2 326 adolescents et jeunes adultes ayant survécu à un cancer, cette étude analyse les facteurs, notamment la présence de maladies chroniques, associés à une augmentation des dépenses de santé
Additional medical costs of chronic conditions among adolescent and young adult cancer survivors
Abdelhadi, Ola A. ; Joseph, Jill ; Pollock, Brad H. ; Keegan, Theresa H. M.
Purpose : Adolescent and young adult (AYA) cancer survivors are more likely to have multiple chronic conditions compared to AYAs without history of cancer. The financial hardship of chronic conditions associated with cancer can substantially impact cancer survivors. We aim to assess health risk behaviors and health care access factors associated with increased medical expenses in AYA cancer survivors. Methods : We utilized 2011–2016 Medical Expenditure Panel Survey (MEPS) data to identify the [...]
Sensibilisation et communication (1)
Menée en République Tchèque auprès de 134 adultes atteints d'un cancer de stade avancé et de 91 aidants familiaux, cette étude de cohorte longitudinale analyse leur connaissance du pronostic et leur communication à ce sujet avec leur oncologue
Prognostic awareness in advanced cancer patients and their caregivers: A longitudinal cohort study
Menée en République Tchèque auprès de 134 adultes atteints d'un cancer de stade avancé et de 91 aidants familiaux, cette étude de cohorte longitudinale analyse leur connaissance du pronostic et leur communication à ce sujet avec leur oncologue
Prognostic awareness in advanced cancer patients and their caregivers: A longitudinal cohort study
Loučka, Martin ; Vlčková, Karolína ; Tučková, Anna ; Poláková, Kristýna ; Houska, Adam ; Matějů, Martin ; Donátová, Zuzana
Objective : The aim of this study was to analyse longitudinal development of prognostic awareness in advanced cancer patients and their families. Methods : This was a longitudinal cohort study, involving 134 adult cancer patients, 91 primary family caregivers and 21 treating oncologists. Key eligibility criterion for patients was life expectancy less than 1 year (estimated by their oncologists using the 12‐month surprised question). Structured interviews, including tools to measure prognostic [...]
